Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05006443 · ClinicalTrials.gov registry record · NA
Staging Classification of Severe Tricuspid Regurgitation Using Novel Cardiac Imaging Techniques
A NA study of Tricuspid Regurgitation, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT05006443: Completed NA study of Tricuspid Regurgitation, sponsored by Mayo Clinic.
NCT05006443 is a NA study of Tricuspid Regurgitation that has completed, run by Mayo Clinic. The registered enrollment target is 75 participants, below the 531-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05006443, a NA study of Tricuspid Regurgitation, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to assess the severity of tricuspid regurgitation (a disorder in which the tricuspid valve in the heart does not close tight enough) using cardiac magnetic resonance imaging (MRI).
Primary Outcome
Incidence of severity of TR by CMR as compared with current gold standard (TTE)
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Cardiac Magnetic Resonance
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2022-01-14 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
What the finished NCT05006443 record still lists
NCT05006443 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 531-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Tricuspid Regurgitation appearing as the primary indexed condition, and to 1 intervention - of which Cardiac Magnetic Resonance is the first listed.
NCT05006443 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05006443 about?
NCT05006443 is a clinical study titled "Staging Classification of Severe Tricuspid Regurgitation Using Novel Cardiac Imaging Techniques". The purpose of this research is to assess the severity of tricuspid regurgitation (a disorder in which the tricuspid valve in the heart does not close tight enough) using cardiac magnetic resonance imaging (MRI).
What is the current status of trial NCT05006443?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2022-01-14. Estimated completion is 2025-04-30.
What conditions does trial NCT05006443 study?
This clinical trial studies the following conditions: Tricuspid Regurgitation.
What interventions are being tested in trial NCT05006443?
The interventions under investigation include: Cardiac Magnetic Resonance (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05006443?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05006443 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tricuspid Regurgitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05006443's enrollment target sits among peer trials
75 10th of 17 higher than 7 of 17 other Tricuspid Regurgitation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tricuspid Regurgitation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TTVR Early Feasibility Study
RECRUITING · NA
-
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
RECRUITING · NA
-
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
RECRUITING · NA
-
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
RECRUITING · NA
-
Trisol System EFS Study
RECRUITING · NA
-
EFS of the DUO System for Tricuspid Regurgitation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI